
The startup is seeking regulatory approval in Europe and the U.S. for the device, which restored vision to patients with late-stage macular degeneration in a small clinical trial.

The startup is seeking regulatory approval in Europe and the U.S. for the device, which restored vision to patients with late-stage macular degeneration in a small clinical trial.